Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial

This meta-analysis of randomized controlled trials aimed to evaluate the effects of probiotic supplementation on glucose homeostasis in patients with polycystic ovary syndrome (PCOS). The meta-analysis was performed in accordance with the Cochrane Handbook guidelines and relevant the preferred repor...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengcheng Zhang, Yingyue Sheng, Jinchi Jiang, Yuzheng Xue, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Jian Jin, Qixiao Zhai
Format: Article
Language:English
Published: Tsinghua University Press 2023-07-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453022002427
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544059688747008
author Chengcheng Zhang
Yingyue Sheng
Jinchi Jiang
Yuzheng Xue
Leilei Yu
Fengwei Tian
Jianxin Zhao
Hao Zhang
Jian Jin
Qixiao Zhai
author_facet Chengcheng Zhang
Yingyue Sheng
Jinchi Jiang
Yuzheng Xue
Leilei Yu
Fengwei Tian
Jianxin Zhao
Hao Zhang
Jian Jin
Qixiao Zhai
author_sort Chengcheng Zhang
collection DOAJ
description This meta-analysis of randomized controlled trials aimed to evaluate the effects of probiotic supplementation on glucose homeostasis in patients with polycystic ovary syndrome (PCOS). The meta-analysis was performed in accordance with the Cochrane Handbook guidelines and relevant the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement criteria. Of 825 identified reports, 11 randomized clinical trials were included in the meta-analysis. An analysis of pooled extracted data revealed that supplementation with probiotics significantly decreased fasting blood glucose (FBG, n = 7; standardized mean difference (SMD) = −0.40; 95 % confidence interval (CI): −2.02, −0.02; P = 0.04) and insulin levels (n = 6; SMD = −0.57; 95 % CI: −0.89, −0.25; P = 0.0004) and the homeostatic model assessment of insulin resistance (n = 7; SMD = −0.64; 95 % CI: −0.96, −0.31; P = 0.0001) while increasing the quantitative insulin sensitivity check index (QUICKI, n = 5; SMD = 0.58; 95 % CI: 0.08, 1.09; P = 0.02) in patients with PCOS. The FBG-reducing effect decreased as the baseline body mass index (BMI) and mean age of the participants increased. Indeed, a greater number of bacterial species and a higher bacterial dose were shown to reduce QUICKI effectively. The systematic review indicated that probiotic supplementation may help to control glucose homeostasis in adults with polycystic ovarian syndrome.
format Article
id doaj-art-60e4f409019f4d558ccaeaf8b63a5c38
institution Kabale University
issn 2213-4530
language English
publishDate 2023-07-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-60e4f409019f4d558ccaeaf8b63a5c382025-02-03T11:09:30ZengTsinghua University PressFood Science and Human Wellness2213-45302023-07-0112410531063Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trialChengcheng Zhang0Yingyue Sheng1Jinchi Jiang2Yuzheng Xue3Leilei Yu4Fengwei Tian5Jianxin Zhao6Hao Zhang7Jian Jin8Qixiao Zhai9State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaDepartment of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaDepartment of Gastroenterology, Affiliated Hospital of Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, ChinaState Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; National Engineering Research Center for Functional Food, Jiangnan University, Wuxi 214122, China; Wuxi Translational Medicine Research Center and Jiangsu Translational Medicine Research Institute Wuxi Branch, Wuxi 214122, ChinaSchool of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, China; Corresponding author at: Jiangnan University, Wuxi 214122, China.State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China; School of Food Science and Technology, Jiangnan University, Wuxi 214122, China; Corresponding author at: Jiangnan University, Wuxi 214122, China.This meta-analysis of randomized controlled trials aimed to evaluate the effects of probiotic supplementation on glucose homeostasis in patients with polycystic ovary syndrome (PCOS). The meta-analysis was performed in accordance with the Cochrane Handbook guidelines and relevant the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement criteria. Of 825 identified reports, 11 randomized clinical trials were included in the meta-analysis. An analysis of pooled extracted data revealed that supplementation with probiotics significantly decreased fasting blood glucose (FBG, n = 7; standardized mean difference (SMD) = −0.40; 95 % confidence interval (CI): −2.02, −0.02; P = 0.04) and insulin levels (n = 6; SMD = −0.57; 95 % CI: −0.89, −0.25; P = 0.0004) and the homeostatic model assessment of insulin resistance (n = 7; SMD = −0.64; 95 % CI: −0.96, −0.31; P = 0.0001) while increasing the quantitative insulin sensitivity check index (QUICKI, n = 5; SMD = 0.58; 95 % CI: 0.08, 1.09; P = 0.02) in patients with PCOS. The FBG-reducing effect decreased as the baseline body mass index (BMI) and mean age of the participants increased. Indeed, a greater number of bacterial species and a higher bacterial dose were shown to reduce QUICKI effectively. The systematic review indicated that probiotic supplementation may help to control glucose homeostasis in adults with polycystic ovarian syndrome.http://www.sciencedirect.com/science/article/pii/S2213453022002427Polycystic ovary syndromeType 2 diabetesGlucose homeostasisProbioticMeta-analysisRandomized clinical trial
spellingShingle Chengcheng Zhang
Yingyue Sheng
Jinchi Jiang
Yuzheng Xue
Leilei Yu
Fengwei Tian
Jianxin Zhao
Hao Zhang
Jian Jin
Qixiao Zhai
Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
Food Science and Human Wellness
Polycystic ovary syndrome
Type 2 diabetes
Glucose homeostasis
Probiotic
Meta-analysis
Randomized clinical trial
title Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
title_full Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
title_fullStr Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
title_full_unstemmed Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
title_short Probiotics supplementation for management of type II diabetes risk factors in adults with polycystic ovarian syndrome: a meta-analysis of randomized clinical trial
title_sort probiotics supplementation for management of type ii diabetes risk factors in adults with polycystic ovarian syndrome a meta analysis of randomized clinical trial
topic Polycystic ovary syndrome
Type 2 diabetes
Glucose homeostasis
Probiotic
Meta-analysis
Randomized clinical trial
url http://www.sciencedirect.com/science/article/pii/S2213453022002427
work_keys_str_mv AT chengchengzhang probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT yingyuesheng probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT jinchijiang probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT yuzhengxue probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT leileiyu probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT fengweitian probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT jianxinzhao probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT haozhang probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT jianjin probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial
AT qixiaozhai probioticssupplementationformanagementoftypeiidiabetesriskfactorsinadultswithpolycysticovariansyndromeametaanalysisofrandomizedclinicaltrial